Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common stock, par value $0.01 per share
-
Shares outstanding
-
52,664,292
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
812,545
-
Shares change
-
+35,257
-
Total reported value, excl. options
-
$6,094,000
-
Value change
-
+$265,795
-
Number of buys
-
5
-
Number of sells
-
-5
-
Price
-
$7.5
Significant Holders of Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) as of Q4 2021
20 filings reported holding MBOT - Microbot Medical Inc. - Common stock, par value $0.01 per share as of Q4 2021.
Microbot Medical Inc. - Common stock, par value $0.01 per share (MBOT) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 812,545 shares
of 52,664,292 outstanding shares and own 1.54% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (269,788 shares), BlackRock Inc. (155,894 shares), AlphaCentric Advisors LLC (100,000 shares), DIMENSIONAL FUND ADVISORS LP (92,779 shares), GEODE CAPITAL MANAGEMENT, LLC (50,504 shares), MORGAN STANLEY (34,784 shares), STATE STREET CORP (34,770 shares), Bank of New York Mellon Corp (15,600 shares), Virtu Financial LLC (12,622 shares), and NORTHERN TRUST CORP (11,878 shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.